A former top adviser to the U.S. effort to develop COVID-19 vaccines has been fired from a board of directors of a medical research firm over sexual harassment allegations, pharmacist GlaxoSmithKline said Wednesday.
The company said it was firing Moncef Slave as chairman of the board of Galvani Bioelectronics, which came into force shortly after an investigation into a complaint against an employee “a few years ago” when Slau worked for a pharmacist.
GlaxoSmithKline is a major shareholder in Galvani Bioelectronics.
Slave has served as chief science adviser for Operation Science Speed, which began during the Trump administration to develop COVID-19 vaccines and treatments.
Slavi failed to comment on Wednesday. Recent emails from Centessa Pharmaceuticals listing Slowney as Chief Scientific Officer and Medicxi listing him as a Partner will not be returned immediately.
GlaxoSmithKline reported that its investigation began after receiving a letter in February alleging “sexual harassment and misconduct”. It said Slavoi’s conduct was “unacceptable” and “abused his leadership position”. It does not detail.
Slaoui spent nearly 30 years at GlaxoSmithKline, playing roles including board of pharmaceutical research և chair of development, chair of global research և development և, according to the Centessa website.